Suppr超能文献

胸腔液中干扰素-γ作为恶性胸膜间皮瘤生存预后因素的评估。

Assessment of interferon-γ in pleural fluid as a prognostic factor of survival in malignant pleural mesothelioma.

机构信息

Clinical Epidemiology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.

Biotherapies Unit, IRCCS Ospedale Policlinico San Martino, Largo Benzi 10, 16132, Genoa, Italy.

出版信息

Cancer Immunol Immunother. 2021 Nov;70(11):3349-3355. doi: 10.1007/s00262-021-02965-w. Epub 2021 May 18.

Abstract

BACKGOUND

Literature reports suggest that the host immune system may control Malignant Pleural Mesothelioma (MPM) growth, although its activity is limited by regulatory mechanisms. In this retrospective study, we analyzed the levels of pro-inflammatory (IL-1, IL-6, TNF), immune-regulatory (IL-10) and Th1/CTL-related cytokines (IL-12p70, IFN-γ) in the pleural exudate and their relationship with overall survival (OS) in MPM.

METHODS

Cytokines were quantified by multiplexed immunoassay. Concentrations were dichotomized with respect to the median value. Correlation between cytokine level and OS was assessed using univariate (Kaplan-Meier curves) and multivariate (Cox regression) analyses.

RESULTS

Regarding outcome, tumor histology, therapies undergone and IFN-γ were independent prognostic factors of OS in a 72 MPM training cohort. Notably, high concentrations of IFN-γ halved death probability (HR of high vs low IFN-γ concentration = 0.491, 95%CI 0.3-0.8, p = 0.007). Also in patients with epithelioid histology and those receiving at least one line of therapy, high IFN-γ level was an independent factor predictive of OS (HR of high vs low IFN-γ concentration were 0.497, p = 0.007 and 0.324, p = 0.006, respectively). However, these data were not confirmed in a 77 MPM validation cohort, possibly due to the low IFN-γ levels encountered in this population, and the heterogeneous distribution of disease stages between the training and the validation cohorts. None of the other cytokines showed any effect on survival.

CONCLUSIONS

High level of IFN-γ in pleural effusion may be associated with better survival in MPM patients and potentially serve as a prognostic biomarker. Larger prospective studies are needed to ascertain this hypothesis.

摘要

背景

文献报道表明,宿主免疫系统可能控制恶性胸膜间皮瘤(MPM)的生长,但其活性受到调节机制的限制。在这项回顾性研究中,我们分析了胸腔渗出液中促炎(IL-1、IL-6、TNF)、免疫调节(IL-10)和 Th1/CTL 相关细胞因子(IL-12p70、IFN-γ)的水平及其与 MPM 总生存(OS)的关系。

方法

通过多重免疫测定法定量细胞因子。根据中位数将浓度分为两组。使用单变量(Kaplan-Meier 曲线)和多变量(Cox 回归)分析评估细胞因子水平与 OS 之间的相关性。

结果

关于结果,肿瘤组织学、所接受的治疗和 IFN-γ是 72 名 MPM 训练队列中 OS 的独立预后因素。值得注意的是,高浓度 IFN-γ使死亡概率减半(高浓度 IFN-γ与低浓度 IFN-γ浓度的 HR=0.491,95%CI 0.3-0.8,p=0.007)。在具有上皮样组织学的患者和至少接受一线治疗的患者中,高 IFN-γ水平也是 OS 的独立预测因素(高浓度 IFN-γ与低浓度 IFN-γ浓度的 HR 分别为 0.497,p=0.007 和 0.324,p=0.006)。然而,这些数据在 77 名 MPM 验证队列中并未得到证实,这可能是由于该人群中 IFN-γ 水平较低,以及训练队列和验证队列之间疾病分期分布不均所致。其他细胞因子均未显示对生存有任何影响。

结论

胸腔渗出液中高水平的 IFN-γ可能与 MPM 患者的生存改善相关,并可能作为一种预后生物标志物。需要更大规模的前瞻性研究来证实这一假设。

相似文献

本文引用的文献

1
Immunotherapy in Malignant Pleural Mesothelioma.恶性胸膜间皮瘤的免疫治疗
Front Oncol. 2020 Feb 21;10:187. doi: 10.3389/fonc.2020.00187. eCollection 2020.
3
Mesothelioma: Scientific clues for prevention, diagnosis, and therapy.间皮瘤:预防、诊断和治疗的科学线索。
CA Cancer J Clin. 2019 Sep;69(5):402-429. doi: 10.3322/caac.21572. Epub 2019 Jul 8.
10
Integrative Molecular Characterization of Malignant Pleural Mesothelioma.恶性胸膜间皮瘤的综合分子特征。
Cancer Discov. 2018 Dec;8(12):1548-1565. doi: 10.1158/2159-8290.CD-18-0804. Epub 2018 Oct 15.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验